Edition:
United States

Deena Beasley

Next big COVID-19 treatment may be manufactured antibodies

2:07am EDT

As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from a class of biotech therapies widely used against cancer and other disorders - antibodies designed specifically to attack this new virus.

Rival drugmakers launch joint trial of medicines for COVID-19

Aug 03 2020

Rival drugmakers AbbVie Inc , Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel coronavirus.

U.S. makes deal for 100 million doses of coronavirus vaccine, deaths expected to rise

Aug 01 2020

Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.

Gilead raises sales outlook to include COVID-19 treatment remdesivir

Jul 30 2020

Gilead Sciences Inc on Thursday posted worse-than-expected quarterly results, but raised its 2020 sales forecast to include revenue from its antiviral drug remdesivir, one of the only treatments shown to help COVID-19 patients.

Amgen second-quarter revenue rises 6%, shares fall 2%

Jul 28 2020

Amgen Inc said on Tuesday second-quarter revenue rose 6% as higher sales of newer drugs, including recently added psoriasis treatment Otezla, offset declining sales of older medicines which were due in some cases to people staying home to avoid exposure to the new coronavirus.

Amgen second-quarter revenue rises 6%, adjusted profit tops Street view

Jul 28 2020

July 28 Amgen Inc on Tuesday reported second-quarter revenue rose 6% as higher sales of newer drugs, including recently-added psoriasis treatment Otezla, offset declining sales of older medicines.

U.S. clears way for drugmakers to share COVID antibody capacity

Jul 23 2020

The U.S. Department of Justice on Thursday said it will not stand in the way of efforts by companies, including Eli Lilly and Co and Amgen Inc, to share information to help scale up capacity to manufacture antibody treatments for COVID-19, the disease caused by the new coronavirus.

Factbox: Five takeaways from Monday's data on experimental coronavirus vaccines

Jul 21 2020

LOS ANGELES Two potential vaccines to protect against the novel coronavirus - one from Oxford University and AstraZeneca Plc and the other from China's CanSino Biologics - induced immune responses in healthy volunteers without causing dangerous side effects, according to studies published on Monday in The Lancet.

World News